Congress trades in Gilead Sciences, Inc. (GILD)
10 of the members we track disclosed 11 purchases of GILD between 2022-09-09 and 2026-05-06, and 14 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How GILD was classified.
How these buys are tagged
3 of these purchases were made by a member whose own committee oversees Healthcare & Pharma. 3 are marked Cluster: A buy is marked Cluster when at least one other tracked member of Congress bought the same stock within 30 days of it, regardless of committee membership.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 11 | +1.2% | +1.1% | 55% |
| Notable (committee-flagged) | 3 | Too few buys to measure | ||
| Unaligned (no committee overlap) | 8 | +3.3% | +3.5% | 62% |
| Cluster, excl. mega-caps | 3 | Too few buys to measure | ||
| Not clustered, excl. mega-caps | 8 | +2.8% | -0.7% | 38% |
Who bought the most
- Josh Gottheimer — 2 buys
- Jared Moskowitz — 1 buy
- Alan Armstrong — 1 buy
- Jefferson Shreve — 1 buy
- Carol Miller — 1 buy
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Jared Moskowitz | 2026-05-06 2026-06-19 |
Unaligned | $136.30 | -2.4% | -5.2% | -3.3% | -16.2% |
| Alan Armstrong | 2026-03-27 2026-07-21 |
Notable | $134.25 | +4.1% | -2.9% | -4.7% | -16.7% |
| Josh Gottheimer | 2026-01-27 2026-02-26 |
Unaligned | $140.97 | +1.6% | +2.0% | -8.3% | -0.8% |
| Jefferson Shreve | 2025-03-31 2025-04-11 |
Unaligned Cluster | $112.05 | -5.8% | -4.9% | -1.1% | +6.6% |
| Carol Miller | 2025-03-10 2025-04-11 |
Notable Cluster | $117.21 | -4.2% | -10.2% | -3.6% | +5.6% |
| Josh Gottheimer | 2025-03-07 2025-04-10 |
Unaligned Cluster | $117.41 | -5.1% | -8.7% | -4.2% | +5.8% |
| Val T. Hoyle | 2024-10-29 2025-09-12 |
Unaligned | $88.08 | +2.4% | +4.9% | +6.6% | +7.8% |
| Tommy Tuberville | 2024-04-05 2024-05-15 |
Notable | $69.58 | -2.2% | -6.9% | -4.2% | -5.0% |
| Greg Stanton | 2023-09-26 2023-11-09 |
Unaligned | $75.53 | -3.0% | +3.9% | +5.9% | +1.6% |
| Dan Goldman | 2023-03-06 2023-04-17 |
Unaligned | $81.11 | -2.0% | +3.1% | -4.2% | -5.5% |
| Zoe Lofgren | 2022-09-09 2022-10-11 |
Unaligned | $65.28 | +0.5% | -1.5% | +34.8% | +29.0% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 14 disclosed sales of GILD are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in GILD are a small part of the full rankings, which score each member across everything they bought.
Data last updated .